Home/Pipeline/Nasodine Nasal Spray

Nasodine Nasal Spray

Common Cold (respiratory viral infection)

CommercialActive

Key Facts

Indication
Common Cold (respiratory viral infection)
Phase
Commercial
Status
Active
Company

About Firebrick Pharma

Australian biotech delivering PVP‑I nasal sprays for rapid viral inactivation and common cold treatment.

View full company profile

Therapeutic Areas